Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment
Top Cited Papers
- 10 August 2011
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 29 (23), 3140-3145
- https://doi.org/10.1200/jco.2011.35.6519
Abstract
Purpose To identify factors associated with outcome after surgical management of intrahepatic cholangiocarcinoma (ICC) and examine the impact of lymph node (LN) assessment on survival. Patients and Methods From an international multi-institutional database, 449 patients who underwent surgery for ICC between 1973 and 2010 were identified. Clinical and pathologic data were evaluated using uni- and multivariate analyses. Results Median tumor size was 6.5 cm. Most patients had a solitary tumor (73%) and no vascular invasion (69%). Median survival was 27 months, and 5-year survival was 31%. Factors associated with adverse prognosis included positive margin status (hazard ratio [HR], 2.20; P < .001), multiple lesions (HR, 1.80; P = .001), and vascular invasion (HR, 1.59; P = .015). Tumor size was not a prognostic factor (HR, 1.03; P = .23). Patients were stratified using the American Joint Committee on Cancer/International Union Against Cancer T1, T2a, and T2b categories (seventh edition) in a discrete step-wise fashion (P < .001). Lymphadenectomy was performed in 248 patients (55%); 74 of these (30%) had LN metastasis. LN metastasis was associated with worse outcome (median survival: N0, 30 months v N1, 24 months; P = .03). Although patients with no LN metastasis were able to be stratified by tumor number and vascular invasion (N0; P < .001), among patients with N1 disease, multiple tumors and vascular invasion, either alone or together, failed to discriminate patients into discrete prognostic groups (P = .34). Conclusion Although tumor size provides no prognostic information, tumor number, vascular invasion, and LN metastasis were associated with survival. N1 status adversely affected overall survival and also influenced the relative effect of tumor number and vascular invasion on prognosis. Lymphadenectomy should be strongly considered for ICC, because up to 30% of patients will have LN metastasis.Keywords
This publication has 19 references indexed in Scilit:
- Intrahepatic CholangiocarcinomaSurgical Clinics of North America, 2010
- Management and Extent of Resection for Intrahepatic CholangiocarcinomaSurgical Oncology Clinics of North America, 2009
- Evidence-Based Approach to Cholangiocarcinoma: A Systematic Review of the Current LiteratureJournal of the American College of Surgeons, 2009
- A Proposed Staging System for Intrahepatic CholangiocarcinomaAnnals of Surgical Oncology, 2009
- Trends in Survival after Surgery for Cholangiocarcinoma: A 30-Year Population-Based SEER Database AnalysisJournal of Gastrointestinal Surgery, 2007
- What prognostic factors are important for resected intrahepatic cholangiocarcinoma?Journal of Gastroenterology and Hepatology, 2007
- Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?Journal of Hepatology, 2004
- AJCC Cancer Staging ManualPublished by Springer Science and Business Media LLC ,2002
- Value of lymph node dissection during resection of intrahepatic cholangiocarcinomaBritish Journal of Surgery, 2001
- Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinomaSurgery, 2000